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Abstract
The role of the heme b in Escherichia coli succinate dehydrogenase is highly ambiguous and its role in catalysis is
questionable. To examine whether heme reduction is an essential step of the catalytic mechanism, we generated a series of
site-directed mutations around the heme binding pocket, creating a library of variants with a stepwise decrease in the
midpoint potential of the heme from the wild-type value of +20 mV down to 280 mV. This difference in midpoint potential
is enough to alter the reactivity of the heme towards succinate and thus its redox state under turnover conditions. Our
results show both the steady state succinate oxidase and fumarate reductase catalytic activity of the enzyme are not a
function of the redox potential of the heme. As well, lower heme potential did not cause an increase in the rate of
superoxide production both in vitro and in vivo. The electron paramagnetic resonance (EPR) spectrum of the heme in the
wild-type enzyme is a combination of two distinct signals. We link EPR spectra to structure, showing that one of the signals
likely arises from an out-of-plane distortion of the heme, a saddled conformation, while the second signal originates from a
more planar orientation of the porphyrin ring.
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Introduction
During aerobic metabolism, Escherichia coli succinate dehydro-
genase (SdhCDAB, complex II) catalyzes the oxidation of
succinate to fumarate and ultimately transfers the chemical energy
to the ubiquinone pool to be used in the terminal reduction of
oxygen by cytochrome oxidase. Located in the bacterial inner
membrane, the enzyme consists of two domains: a soluble SdhAB
dimer that is bound to the inner membrane by the SdhCD
transmembrane domain. The oxidation of succinate occurs at a
flavin adenine dinucleotide (FAD) cofactor that is covalently
attached to a histidine in the SdhA subunit. The oxidation of
succinate to fumarate releases two electrons (and 2 H
+) that are
transferred directly to the FAD cofactor, itself a two-electron (and
hydrogen) carrier. These electrons must sequentially tunnel
through a series of three iron-sulfur ([Fe-S]) clusters – a [2Fe-2S]
FS1, [4Fe-4S] FS2, and [3Fe-4S] FS3, in that order – that form an
electron transfer relay through the SdhB subunit. We have
previously shown that electrons from FS3 can directly reduce
ubiquinone at a quinone-binding site (Q-site) located 8.4 A ˚ (edge-
to-edge distance) from FS3 [1]. A complete 2-electron reduction of
the quinone proceeds via a stable, EPR-detectable ubisemiquinone
intermediate [1].
Located inthe middle of the membrane, sandwiched between the
SdhC and SdhD subunits is a bis-histidine-coordinated b-type
heme. One histidine residue from each of the SdhC and SdhD
subunits provides the two ligands to the heme iron. The heme is
conserved in the complex II family of enzymes [2–5] but it does not
lie in the direct pathway of the electron transfer relay between the
FAD and Q-site. While the heme cycles through redox states in the
presence of succinate and quinones, this redox activity does not
appear to be essential for enzyme function as a heme-free variant
retains a significant amount of catalytic activity and is capable of
supporting the growth of E. coli on succinate [6]. The E. coli Sdh
paralogue fumarate reductase (FrdABCD, Frd) lacks heme and
catalyzes the reduction of fumarate to succinate. However, over-
expressed FrdABCD can catalyze succinate:ubiquinone oxidore-
ductase activity sufficient to complement an sdh deletion strain [7].
Although it is clear that the heme is necessary to stabilize the
structure of the isolated Sdh enzyme [6,8] the exact function of this
heme cofactor in electron transfer remains to be determined.
The mitochondrial respiratory chain is a significant source of
free radicals but the contribution of complex II to the overall
generation of reactive oxygen species (ROS) is relatively minor.
Through an auto-oxidative process, E. coli Sdh normally produces
low quantities of ROS in the form of superoxide [9], however,
mutations around the Q-site in E. coli (and also Saccharomyces
cerevisiae Sdh) can lead to an increased rate of superoxide
production [10,11]. It has been suggested that the heme is
behaving as an electron buffer to prevent the production of ROS
from a Q-site-stabilized ubisemiquinone [4] but experimental
evidence for this is lacking.
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32641The redox potential (Em,7) of the heme in E. coli Sdh is +20 mV
[12]. This is in contrast to published values for the heme in bovine
complex II which has an Em,7 of 2185 mV [13]. It is for this
reason that the heme in mammalian complex II cannot be
reduced in the presence of succinate [13] but the heme of E. coli
Sdh can be reduced by succinate and oxidized by ubiquinone
[1,14].
The loss of the heme in E. coli Sdh is accompanied by a decrease
in catalytic rates [6], which may arise from improper, yet
competent, folding of the membrane subunits, but could also
result from dysfunctional electron tunneling pathways. To
examine the latter, we used a directed mutagenesis approach to
alter the midpoint potential of the heme and measured the effects
of altered heme redox chemistry on enzyme activity and ROS
production. A biophysical characterization of these Sdh variants
reveals the heme can exist in two distinct conformations that differ
in planarity of the porphyrin ring. This is the first evidence of
structural heterogeneity of the heme in this family of enzymes and
the significance of out-of-plane distortion of the porphyrin ring is
discussed.
Materials and Methods
Site-directed mutagenesis
The EcoRI/BamHI fragment of the pFAS plasmid [7]
containing the sdhCDAB operon was subcloned into the cloning
vector pTZ18R ((Amp
R, lacZ9), GE healthcare). This plasmid was
used as a template for site-directed mutagenesis to introduce the
required single mutations according to the QuikChange procedure
(Stratagene). The mutagenic oligonucleotides (Integrated DNA
Technologies) used in the PCR reactions are listed in Table S1.
All mutations were confirmed by DNA sequencing (DNA Core
Facility, Department of Biochemistry, University of Alberta). In
order to create double mutations, the KpnI/BamHI fragment of
the plasmid bearing the SdhC
V87D mutation was cut out and
reinserted into the plasmid containing the appropriate second
mutation. Once all mutagenesis was complete, the EcoRI/SphI
fragment was subcloned back into pFAS and transformed into E.
coli strain DW35 (DfrdABCD, sdhC::kan), a strain that does not
contain any wild type Sdh or Frd [15]. All genetic manipulations
were done in the E. coli strain TG1 ((hsdD5 thi D(lac-proAB)
F9[traD36 proAB+lacIq lacZDM15]), Amersham Biosciences)).
Isolation of crude membranes
E. coli DW35 expressing Sdh variants was grown in TB media
overnight for 16–18 hours using a 1:100 starter inoculum as
reported previously [1]. After harvesting, cells were lysed by
multiple passes through an Avestin Emulsiflex in the presence of
20 mM phenylmethylsulfonyl fluoride. The bacterial inner mem-
brane fraction was isolated using differential centrifugation as
previously described [1]. During the procedure, membranes were
incubated at 30uC for 15 minutes with 1 mM malonate to remove
oxaloacetate bound at the FAD site of Sdh. All cells and
membrane isolations were maintained in 100 mM MOPS/
5 mM EDTA buffers.
Protein quantitation
To assess the overall expression and assembly of SdhCDAB, all
membrane samples were examined after electrophoresis on a
12.5% SDS-PAGE gel [6]. 45 mg of membranes were loaded
alongside a low molecular weight ladder (Bio-Rad) and stained
with Coomassie blue. Protein concentrations were quantitated
using the Lowry assay [16] and Sdh levels quantitated by
measuring covalent-flavin [17].
Enzyme activity assays
The succinate/Q0 and plumbagin/fumarate assays were
performed as described previously [1]. In order to calculate kcat
and Km values, the Q0 or plumbagin concentration was varied
from 0.07 mM to 0.3 mM and data was plotted to an Eadie-
Hofstee graph. The succinate/phenazine methosulfate (PMS)/3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)
assay was performed as before [14].
UV-VIS and EPR spectroscopy
Reduced minus oxidized absorbance spectra were recorded on a
Hewlett Packard 8453 UV-VIS diode array spectrophotometer.
Membranes were diluted to a protein concentration of
0.5 mg mL
21 in degassed 100 mM MOPS/5 mM EDTA buffer
(pH 7.0). Samples were reduced with either excess sodium
dithionite, or 9 mM sodium succinate.
Potentiometric titrations were performed as previously de-
scribed [1]. Protein concentrations within the EPR samples varied
from 20–30 mg mL
21. Oxidized membrane samples were made
by adding 2,6-dichlorophenolindophenol (DCPIP) to a final
concentration of 0.8 mM [6]. All samples were made using
standard 3 mm diameter quartz EPR tubes and stored in liquid
nitrogen until anazlyzed. EPR spectroscopy was performed on
either a Bruker Elexsys E500 or Bruker ESP300E EPR
Spectrophotometer, each equipped with an Oxford Instruments
ESR900 flowing helium cryostat. Both [3Fe-4S] and heme b EPR
spectra were recorded at 12 K, 20 mW at 9.47 GHz, 10Gpp.
Measurement of reactive oxygen species
A cytochrome c reduction assay was used to quantitate the
production of superoxide during enzyme turnover [9]. A disc assay
was used to measure the susceptibility of E. coli to oxidative stress.
Sloppy agar overlays of the appropriate E. coli culture were made.
0.7 cm-wide discs of Whatman no. 1 filter paper were placed atop
the overlays and 3 ml of a 0.5 mM or 0.25 mM solution of methyl
viologen was added to the centre of each disc. The plates were
incubated overnight at 37uC and the diameter of the resulting
zone of inhibition was measured along two orthogonal axes.
Results and Discussion
Selection of Residues to Mutate
Using site-directed mutagenesis, we modulated the redox
potential of the heme by replacing residues within its second
coordination sphere. We selected non-conserved residues in the
immediate vicinity of the heme (within 5 A ˚ of the heme edge) using
theX-raystructure (pdb code:1NEK [4])asa guide,andfocusedon
residues with sidechains pointed directly at the heme (Figure 1).
When measuring effects on catalytic activity, we concentrated only
on these mutations to non-conserved amino acids located away
from the propionates and the Q-site, in order to avoid effects
unrelated to the heme potential (Table 1). Another set of mutations
was generated at residues positioned around the heme propionates;
however, these variants were only characterized for their biophys-
ical properties and were not included in our analysis of catalytic
turnover. These latter variants are discussed below.
In contrast to the soluble domains of E. coli Sdh and eukaryotic
complex II, the membrane domains share very low sequence
identity [2]. When conserved residues are mapped onto the
available Sdh crystal structures, the majority of these residues in
SdhC and SdhD are confined to key areas of the enzyme near the
Q-site and heme propionates (not shown). Despite the fact that
both share the same core 4-helix bundle-type structure, the
individual residues along those helices show significant variation.
Heme b of Succinate Dehydrogenase
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backbone a-carbons are well conserved even though the individual
residues are not. Due to the bis-histidine coordination of the heme
and common architecture conserved in both E. coli and eukaryotic
enzymes, the amino acids side chains adjacent to the heme align
well, spatially, when comparing the structures of E. coli Sdh to
avian or porcine complex II (pdb codes 1ZOY [2] and 2H88 [3],
respectively). We noticed that the heme binding pocket is much
more polar in mitochondrial complex II than in E. coli Sdh. Of the
residues we chose to mutate, many of the nonpolar residues were
mutated to the polar residue found at the equivalent position in the
mitochondrial enzyme.
Expression and Membrane Assembly of Variant Sdh
Enzymes
The mutations introduced into the SdhCD membrane domain
did not have a detrimental effect on the expression and assembly
of the enzyme as determined by SDS-PAGE analysis of crude
Figure 1. Residues selected for mutation. Upon mutation, residues that result in a shift towards the ‘‘sharp’’ EPR spectrum are colored in yellow
while positions causing a shift towards the ‘‘broad’’ EPR spectrum are colored in blue. Residues that did not affect the EPR spectrum when mutated
are shown in green. (pdb: 1NEK [4]).
doi:10.1371/journal.pone.0032641.g001
Table 1. Redox characteristics, physiological and non-physiological activity, and ROS assays of wild-type and Sdh variants.
Variant Em,7 heme b Em,7 [3Fe-4S] kcat Q0 (s
21)
kcat/Km Q0
(610
6 M
21 s
21)
kcat PMS-
MTT(s
21)k cat PB (s
21)
Disc Assays
(cm
2)
ROS production
(s
21)
SdhCDAB 20 60 42.960.4 0.2960.06 19.960.2 39.661.5 1.73 2.060.4
D-V19D 2 55 30.063.3 0.2360.03 23.260.8 n.d. n.d. n.d.
D-A23D 254 0 3 5 . 7 61.3 0.2660.01 20.960.7 n.d. n.d. n.d.
C-F38D 210 50 38.162.6 0.2860.04 20.960.6 35.761.1 1.19 1.260.4
C-V85D 213 55 14.860.4 0.2960.05 11.460.4 n.d. n.d. n.d.
C-T37I 222 50 30.362.2 0.2260.02 16.560.7 29.261.5 n.d. n.d.
C-F38S 225 40 37.364.7 0.2460.06 20.460.8 n.d. 1.31 1.660.1
C-H30A/C-V87D 230 45 29.763.1 0.1760.03 21.260.4 n.d. n.d. n.d.
D-A23S 240 60 27.162.0 0.1660.02 11.060.3 27.961.1 n.d. n.d.
C-V87D 243 35 34.161.8 0.2060.03 22.960.8 n.d. n.d. n.d.
C-V85T 245 60 44.861.0 0.3660.02 26.261.5 54.261.8 n.d. 2.860.3
C-H30G 250 45 27.962.0 0.2260.03 12.960.2 n.d. 1.17 0.860.1
C-H30A 254 53 32.463.3 0.2160.03 17.660.4 29.861.2 n.d. n.d.
C-H30S 262 40 35.362.0 0.2160.04 21.560.9 n.d. n.d. n.d.
C-F38D/C-V87D 280 60 13.361.7 0.0560.01 15.960.2 21.661.0 1.61 0.860.1
Turnover numbers have all been normalized to FAD content. Activity data were averaged from at least three independent measurements.
doi:10.1371/journal.pone.0032641.t001
Heme b of Succinate Dehydrogenase
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e32641membranes prepared from bacterial cultures over-expressing each
of the variants (Figure S1). A standard covalent-flavin assay was
used to quantify the amount of SdhA in each sample; levels of
FAD varied between 1.5–2.5 nmol FAD mg
21 total protein and
correlated well with SdhA levels seen on the SDS-PAGE gel.
We utilized the PMS-MTT assay to measure non-physiological
succinate oxidation activity of the enzyme. This assay requires
only a functional SdhAB dimer and thus it is a measure of overall
expression and insertion into the membrane. As shown in Table 1,
the PMS-MTT activity of the variants was similar to that of wild-
type Sdh, although the SdhD
A23S, SdhC
V87D, and SdhC
H30G
variants had somewhat lower activity. Thus, mutations in the
membrane domain did not significantly alter the ability of the
enzyme to oxidize succinate to fumarate.
Determination of the Midpoint Potential of Heme b in
Variant Sdh Enzymes
We used a combination of redox potentiometry and EPR
spectroscopy to determine the midpoint potential of the heme in
all Sdh variants (Table 1). We also measured the midpoint
potential of the [3Fe-4S] FS3 cluster, which should be unaffected
by mutations in the transmembrane domain. The midpoint
potential of the FS3 cluster was not significantly altered in any of
the Sdh variants (Em,7=+60 mV).
In wild-type E. coli Sdh, the midpoint potential of the heme is
+20 mV. Using site-directed mutagenesis, we successfully generated
variants with a wide range of heme potentials, from +2 mV down to
280 mV. In all the variants, the heme remained hexa-coordinate
and low-spin. In some cases, a single amino acid residue difference
was enough to drop the redox potential of the heme by as much as
75 mV and a combination of the SdhC
F38D and SdhC
V87D
mutations had a cumulative effect, resulting in a 100 mV change.
As expected, the introduction of an Asp residue into the low
dielectric environment of the heme resulted in drops of 20–60 mV
in the heme potential depending on the position of the mutation.
Negatively charged amino acids are expected to stabilize the
oxidized form of the heme, which is cationic. This is consistent
with results in synthetic heme protein maquettes in which the
addition or subtraction of a single charged amino acid in the
vicinity of a bis-His coordinated heme yielded a change in heme
redox chemistry of approximately 650 mV [18].
Interestingly, none of the mutations resulted in an increase in
heme potential, even when the heme microenvironment is made
more hydrophobic (as in the SdhC
T37I or SdhC
H30A variants). In
these cases, the lower dielectric within the protein milieu might be
expected to raise the Em of the heme through stabilization of the
electronically neutral ferrous heme state. Instead, the redox
potential of the heme dropped 40–75 mV in these variants. This
highlights the inherent unpredictability in these types of experi-
ments. In these cases, the counterintuitive result may be due to
increased solvent exposure of the heme (in the X-ray structures,
SdhC
H30 appears to shield the heme cofactor from nearby water
molecules) or differential packing against the hydrophobic core,
which may instead stabilize the oxidized form of the heme [18].
As noted above, a comparison of residues immediately next to
the heme cofactor indicate that the heme binding pocket in the
eukaryotic complex II is much more polar than in E. coli Sdh. In
our experiments, individual amino acid mutations in E. coli Sdh
can decrease the redox potential of the heme by up to 75 mV.
Given the cumulative nature of these amino acid replacements, the
increased dielectric environment is likely a major cause of the
200 mV difference between the midpoint potential of the heme in
mitochondrial complex II (Em,7=2185 mV [13]) and E. coli Sdh
(+20 mV).
The low redox potential of the heme in mitochondrial complex
II is very similar to that measured in the Sdh of Paracoccus
denitrificans (Em,7=2176 mV ([19]), a bacterium thought to be the
possible ancient ancestor of the mitochondrion [20]. This range of
heme potentials is not much higher than the potential of bis-
imidazole-ligated heme b in solution (Em8.5=2235 mV) [21].
Considering the unusually high midpoint potential of the heme in
E. coli Sdh and the ease by which mutations around it are able to
lower its potential, it may be a case that in the E. coli enzyme, the
heme-binding pocket has evolved to maximize the Em of the heme.
This suggests a non-structural role for the heme since its redox
potential would be irrelevant in an exclusive role as a molecular
chaperone. Since the heme in mitochondrial complex II is not
reducible by succinate [13], but it can be succinate-reduced in E.
coli Sdh [1], this suggests that if the heme in E. coli Sdh serves a
non-structural role, this function is unlikely to be conserved in the
mitochondrial enzyme.
Visible Spectroscopy of Heme b in Sdh Variants
Each of our variants exhibit typical room temperature heme
absorption spectra with Soret maxima at 410 nm and 427 nm in
the oxidized and reduced state, respectively (data not shown).
Normal b- and a- band absorbance maxima at 542 nm and
560 nm were also observed. This suggests that the heme
environment is not dramatically altered as a result of the
mutations. When succinate instead of dithionite was used to
reduce the heme, the levels of reduced heme reflected the EPR-
determined midpoint potential. In the SdhC
F38D/SdhC
V87D
double variant with the lowest redox potential, succinate-reducible
heme comprises only 10% of wild-type Sdh level. This 10% signal
may not derive entirely from reduced Sdh heme, and may be a
result of redox equilibrium with the downstream hemes of the E.
coli cytochrome oxidases [22] (Figure S2).
Catalytic Characterization of Variant Enzymes
In order to assess the effect of heme potential on catalytic
turnover, we measured the ability of the variant enzymes to reduce
the ubiquinone analogue, Q0, in the presence of excess succinate.
As shown in Table 1, all of the variants were catalytically active.
Wild-type Sdh reduces Q0 with a kcat of 43 s
21. Although most of
the variant proteins had a decreased capacity to reduce quinone,
we could not see a correlation between the midpoint potential of
the heme and Q0-reductase activity, confirming that heme
reduction is not essential for catalytic function. We only observed
dramatic decreases in quinone reduction activity in the cases of the
SdhC
V85D and SdhC
F38D/SdhC
V87D variants, which may be
caused by secondary effects to enzyme structure. In most cases, we
measured a 10–40% decrease in the catalytic activity of the
enzyme. This range of activity is reasonable since a complete loss
of the heme cofactor only attenuates activity by roughly 50% [6].
The SdhC
V85T variant, which has a heme Em,7 of 245 mV
(65 mV lower than wild-type Sdh), retained wild-type levels of Q0-
reductase activity. As well, none of the mutations had a significant
effect on the Km for Q0. This suggests that quinone binding is not
affected by any of the mutations, as predicted from their
substantial distance from the Q-site. Additionally, there was no
strict correlation between the catalytic efficiency of the quinone
reduction (kcat/Km) and the midpoint potential of the heme
(Table 1).
Fumarate Reductase Activity of Variant Sdh Enzymes
SdhCDAB is able to catalyze the reverse reaction, the quinol-
dependent reduction of fumarate, when supplied with a source of
reducing equivalents. We measured the ability of the variant
Heme b of Succinate Dehydrogenase
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menaquinone analogue, reduced plumbagin, and as shown for
the forward reaction, little correlation was observed between Em
and activity (Table 1). In all variant enzymes that we tested,
plumbagin oxidation rates were directly proportional to Q0
reduction rates. Thus, we have shown that in vitro, modulating
the midpoint potential of the E. coli Sdh heme does not have a
definite effect on the ability of the enzyme to reduce quinone or
oxidize quinol substrates.
Reactive Oxygen Production in vitro
It has been suggested that the FAD is the major site of
superoxide production in Sdh [9]. The high potential of the heme
may allow it to draw electrons away from the FAD. Lowering the
potential of the heme would increase ROS production as electrons
accumulate at the FAD. Alternatively, the heme may act as an
electron sink in order to prevent the formation of ROS via the
stable ubisemiquinone intermediate. In this case, a reduced
capacity for electrons at the heme should increase the lifetime of
the ubisemiquinone intermediate and thus increase the production
of superoxide from the Q-site.
We examined the effect of lower heme midpoint potential on
the production of ROS by measuring the production of superoxide
during enzyme turnover using a cytochrome c reduction assay
(Table 1). Wild-type Sdh produces superoxide at a rate of
approximately 2 s
21. All of the variant enzymes tested produced
superoxide at a rate equivalent to wild-type Sdh when normalized
to catalytic turnover, which was approximately 5% the rate of Q0
reduction. Thus, lowering the redox potential of the heme has no
appreciable effect on the production of ROS in this enzyme.
Reactive Oxygen Production in vivo
We determined whether these variant enzymes could be
producing increased levels of superoxide in vivo. Disc assays were
performed on DW35 cells expressing wild-type as well as the Sdh
variants (Table 1). When 1.5 mmol of paraquat was added to the
0.6 cm filter discs, the zone of growth inhibition around the cells
expressing wild-type Sdh was 1.7 cm
2. The corresponding zones of
inhibition surrounding the DW35 cells expressing the variant Sdh
enzymes were in every case smaller when compared to those cells
expressing wild-type Sdh. Paraquat sensitivity was not enhanced in
any of the variant enzymes tested and similar results were obtained
when 0.75 mmol of paraquat was used (not shown). These results
mirror the in vitro results: superoxide production was not increased
as the redox potential of the heme was decreased.
We have yet to find any evidence that changes to the physical
properties of the heme can lead to an increased production of
superoxide, either in vivo or in vitro. At this point, it is highly unlikely
that the heme is actively involved in ROS suppression in this
enzyme.
EPR Characterization of Heme b in Variant Sdh Enzymes
The b heme of E. coli Sdh exhibits a highly anisotropic low spin
(HALS)-type EPR signal characterized by a large gz feature (gz.3)
[23]. The HALS signal is a result of strain on the heme iron, due
to the near perpendicular orientation of the imidazole sidechains
belonging to the two histidine ligands [24,25]. In wild-type Sdh,
the EPR lineshape of the ferric heme consists of two components
that likely arise from two distinct conformations of the heme. As
shown in Figure 2, the heterogeneous signal observed is a
combination of a sharp signal at gz=3.66 and a broad signal
centered at gz=3.55. Mutations such as SdhC
H30A can shift the
equilibrium towards the sharp species, whereas the EPR spectrum
of the SdhC
T37I mutation is almost entirely the upfield broad
species. Due to the high g anisotropy of these HALS-type hemes,
gx and gy values are difficult to measure.
Figure 3 shows the EPR spectra of the oxidized heme in all the
Sdh variants included in this study. The SdhD
V19D mutation
resulted in the most dramatic change in the EPR lineshape of the
heme, but this effect was unique to this enzyme. Here, we
observed the appearance of a new rhombic species at g=3.00 in
addition to the regular signal in the g=3.5–3.6 range and these
two signals both titrate to the same midpoint potential (Table 1).
Given the low g anisotropy of this new species, this signal likely
arises from an isomeric fraction of the enzyme in which the two
histidine ligands are coplanar. The addition of an Asp residue in
position 19 of SdhD likely disrupts the normal orientation of the
nearby SdhD
H71 ligand during assembly of the heme, leading to
the incorporation of other rotamers of that imidazole sidechain.
In these experiments and previous studies by Cheng et al. [12],
we observed Sdh variants that appear to shift the equilibrium
towards one of the two conformational states that exist in wild-type
Sdh (Figure 3). The positions of these altered amino acids and
their consequences on the EPR signals provide indirect evidence
Figure 2. Ferric heme EPR lineshapes of the two heme conformations. The signal in wild-type Sdh is a mixture of a sharp and broad species,
exemplified in the SdhC
H30A and SdhC
T37I variants, respectively.
doi:10.1371/journal.pone.0032641.g002
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consequence of out-of-plane distortions of the porphyrin ring.
Although energetically unfavorable, distortion of the heme away
from planarity is common in Fe-porphyrins [26] and is heavily
influenced by the surrounding protein milieu [27,28].
Out-of-plane distortions of the porphyrin ring are normally
dependent on hydrogen bonding with the heme propionates and
van der Waals contacts with the porphyrin ring. In model heme
systems, possible distortions include saddled, ruffled, domed,
waved, and propellering conformations [29,30], although it is
the two former configurations that are most commonly observed.
We believe that a saddled porphyrin ring is the origin of one of the
observed EPR lineshapes, while the other is due to a more planar
orientation of the porphyrin. This is consistent with more recent
crystal structures of the E. coli Sdh, which modeled the heme in a
more saddled conformation [31]. This is in contrast to the initial
1NEK structure that modeled the heme in a near planar
conformation [4]. While the high resolution structural data hints
at the two conformational states, the following biophysical data
also suggests that this phenomenon is real and not an artefact of
the crystallography.
An examination of the hydrogen-bonding network around the
heme propionates reveals some interesting results. SdhC
H91,
SdhB
H207, and SdhD
R20 form a hydrogen-bonding network with
the propionate distal to the Q-site. SdhD
Q78 and SdhC
R31 are
hydrogen-bonded to the proximal propionate (Figure 4). In the
2WDV X-ray structure containing the saddled heme, the pyrrole
ring associated with the distal propionate is shifted towards
Figure 3. EPR Spectra of low-spin heme. Crude membranes enriched in wild-type SdhCDAB and Sdh variants were oxidized with 0.8 mM DCPIP.
DW35 membranes do not contain Sdh enzyme and serve as the negative control. Spectra were recorded at 20 mW at 12 K.
doi:10.1371/journal.pone.0032641.g003
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R20 while the proximal pyrrole ring contorts in the opposite
direction, towards SdhD
R31. Along the pseudo two-fold axis of the
heme, SdhD
R20 and SdhC
R31 are in equivalent positions, as are
SdhC
H91 and SdhD
Q78. These residues surrounding the heme
propionates are generally well conserved among different complex
II homologs.
Mutations around the heme propionates reveal an interesting
symmetry. The SdhD
R20L and SdhC
R31L mutations result in a
shift towards the broad EPR spectrum at gz=3.55
(Em,7=225 mV and +15 mV, respectively), although the effect
is not as pronounced in the SdhD
R20L variant. Conversely, the
SdhC
H91L and SdhD
Q78L [12] mutations (Em,7=230 mV and
+8 mV [12], respectively) both cause a shift towards the sharp
species at gz=3.66 (Figure 3). The mutation of any one of these
‘‘girder’’ residues is likely to cause the heme propionate to shift
towards the remaining residue, resulting in the equilibrium shift
towards planarity or distortion. For example, in the case of the
SdhC
H91L mutation, the distal propionate will shift towards
SdhD
R20, and vice versa. When considering mutations to the
hydrogen-bonding network of the propionates, the symmetry
strongly suggests that one of the species seen by EPR is the heme
in a saddled conformation, as this particular distortion is
characterized by the same two-fold symmetry. The crystal
structure of the SdhB
H207T was recently elucidated [32] and
shows the distal propionate shifted towards SdhD
R20. This is the
same configuration that is expected in the SdhC
H91L mutation and
consistently, both the SdhC
H91L and SdhB
H207T variants
(Em,7=+20 mV [32]) exhibit the same sharp EPR spectra.
Additionally, in the SdhB
H207T variant, the heme in that crystal
structure has been modeled as less distorted than in the 2WDV
structure, which shows the most heme distortion. This suggests
that the sharp EPR species may represent a relatively more planar
conformation.
Mutations to amino acids packed against the face of the
porphyrin ring can also shift the equilibrium between the saddled
and planar conformations. SdhC
H30 is in close van der Waals
distance (,3.5 A ˚) to the top, distal pyrrole ring of the heme (ring
A, Figure 5) (we refer to the propionate end as the top of the
heme). In all the crystal structures, this pyrrole ring appears to be
most distorted from planarity, and the position of SdhC
H30
suggests that this residue strongly contributes to the out-of-plane
distortion of that ring. We expect the loss of this residue will relieve
steric forces on the heme and result in a more planar orientation of
the porphyrin molecule. Consistent with this, when we mutated
SdhC
H30 we noted a shift in equilibrium towards the sharp EPR
species.
The SdhC
V87D mutation also results in the observation of the
sharp species. This residue is located at a farther distance from the
heme (9 A ˚) but the Asp residue here likely interacts with the
nearby SdhC
H30 residue, pulling the latter residue away from the
heme, and leading to increased planarity in the porphyrin ring.
Considering these results and the SdhB
H207T crystallographic
data, we can confidently assign the sharp EPR species as
originating from a more planar conformation of the heme,
whereas the broad component of the lineshape is derived from a
more saddled distortion.
Figure 4. The hydrogen-bonding network around the heme propionates. The distal propionate is highlighted on the left while the proximal
propionate is shown on the right. Each propionate is held in position by residues on either side. Mutation of SdhD
R20 and SdhC
R31 to a Leu results in
the propionate shifting towards the other ‘‘girder’’ (light arrows). Mutation of SdhC
H91 and SdhD
Q78 to a Leu causes a shift of the propionate in the
other direction (dark arrows). Note the twisting of the porphyrin ring into a saddled conformation in this structure. (pdb: 2WDV [31]).
doi:10.1371/journal.pone.0032641.g004
Figure 5. Interactions between the heme face and surrounding
residues. Mutations to the residues depicted are able to affect the
planarity of the porphyrin ring. Pyrrole rings are denoted as (A) top,
distal (B) top, proximal (C) bottom, proximal (D) bottom, distal. (pdb:
2WDV [31]).
doi:10.1371/journal.pone.0032641.g005
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also able to elicit the same spectroscopic shifts as those along the top
edge of the heme. Here, the SdhD
A23S mutation gives rise to a
broad signal, however, the gz value is shifted upfield to g=3.40.
Thisshiftislikelyaresultofinteractionsbetween theserinehydroxyl
and the nearby heme ligand, SdhD
H71, which may reduce the
perpendicularity between the two histidine ligands. SdhC
V85 lies at
an equidistant position on the opposing side of the bottom, distal
pyrrole ring (ring D, Figure 5)a sS d h D
A23 and we can observe a
similar symmetry in the EPR spectra as with the mutations around
the heme propionates. In a saddled conformation, the distal, bottom
pyrrole ring would be displaced away from planarity towards
Sdh
CV85. The introduction of a polar Ser or Thr juxtaposed with
the relatively hydrophobic pyrrole ring should displace the ring
away from the hydroxyl. Thus, the SdhC
V85T mutation should
increase planarity (sharpEPRspecies)while theSdhD
A23Smutation
should decrease planarity (broad EPR species). Our results are
consistent with this. Unexpectedly, when an Asp residue is mutated
into either of the two positions, we did not see a change in the EPR
spectroscopic characteristics of the heme. Here, is it likely that the
increased length of the Asp sidechain positions the carboxyl too far
away to interact with the neighboring pyrrole ring.
SdhC
T37 is situated next to the proximal, bottom pyrrole ring
(ring C, Figure 5), but its hydroxyl group is pointed away from
the heme and as such the dipole here may not be interacting
directly with the porphyrin ring. The SdhC
T37I mutation
introduces a much bulkier sidechain at this position, which would
force the proximal, bottom pyrrole ring away for steric reasons,
favoring a more saddled porphyrin conformation. Hence, we
observe the broad EPR species in this variant (gz=3.55).
Of note, mutations associated with increased planarity of the
porphyrin molecule are also associated with lower midpoint
potentials. Distorted porphyrin systems result in decreased
electron density at the heme iron and an increase in redox
potential [33]. This trend does not hold when considering
mutations around the propionates but this is likely due to
unpredictable changes in the hydrogen-bonding network. How-
ever, there is consistent support for saddled distortions in the E. coli
Sdh heme. Future crystallographic studies on these Sdh variants
will be needed to provide direct evidence of heme distortion.
Summary
We made mutations in E. coli Sdh that modulated the midpoint
potential of the heme by nearly 100 mV and assessed the effect on
the catalytic ability of the enzyme. Although many of our variants
had subtle effects on activity compared to wild-type Sdh, we could
not observe a correlation between heme Em and catalytic turnover.
In addition, we did not find evidence that the heme is involved in
the suppression of ROS, either in vitro or in vivo.
Studies have shown that in the c-type cytochromes, out-of-plane
distortions can be conserved among protein homologs across
different organisms [30]. The conservation of what is an
energetically unfavorable process suggests some purpose for such
higher order structures. Here, an examination of the biophysical
data suggests that in the ferric state, the heme cofactor in wild-type
Sdh exists in a heterogenous population of saddled and planar
conformations. The saddling of the heme likely contributes to its
high midpoint potential in this particular complex II homolog.
In this study, we did not observe a link between heme structure
and in vitro turnover, but since the heme can adopt at least two
physically distinct forms, it is an enticing possibility that redox-
linked conformational changes may be a possible mechanism to
regulate some aspect of enzyme activity, in vivo. Heme conforma-
tions can be affected by redox state due to the differences in pyrrole
(Fe-N) bond lengths between the ferric and ferrous states [34,35].
Already, it has been demonstrated that other cytochromes are
capable of large-scale conformational changes associated with the
redox state of their heme cofactors [36,37]. A conformational shift
between a saddled and planar state during redox cycling could be
communicated throughout the structure of the membrane domain,
given the face of the heme is in van der Waals contact with a large
portion of the transmembrane helices. As well, the heme
propionates are hydrogen bonded to key residues that constitute
the Q-site and minor changes here could impact the enzyme affinity
for the ubiquinone pool. If the heme is acting as a molecular sensor
of the redox state of the quinone pool in vivo, a redox-induced
conformational change could provide a possible mechanism.
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Figure S1 SDS-PAGE gels of Sdh-enriched membranes.
Expression levels of each Sdh subunit are similar in all the
mutants. Lane 1, SdhCDAB. Lane 2, SdhD
V19D. Lane 3,
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SdhC
H30G. Lane 13, SdhC
H30A. Lane 14, SdhC
H30S. SdhC
F38D/
SdhC
V87D.
(TIF)
Figure S2 Succinate-reduced minus air-oxidized absor-
bance spectrum. The 100 mV decrease in heme Em in the
SdhC
F38D/SdhC
V87D mutant significantly diminishes its succinate
reduction capacity. The DW35 membranes were reduced with
dithionite to show levels of b-type hemes in cytochromes bo3- and
bd- oxidase. Sdh-enriched membranes are expected to have less
contaminating b-type hemes due to Sdh overexpression.
(TIF)
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the appropriate mutagenic oligonucleotide in each PCR reaction.
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